The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
8-Cyclohexylamino-7-fluoro-1-methyl-4-oxo-1,4-dihydro-benzo[b][1,8]naphthyridine-3-carboxylic acid ID: ALA353607
PubChem CID: 484067
Max Phase: Preclinical
Molecular Formula: C20H20FN3O3
Molecular Weight: 369.40
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cn1cc(C(=O)O)c(=O)c2cc3cc(F)c(NC4CCCCC4)cc3nc21
Standard InChI: InChI=1S/C20H20FN3O3/c1-24-10-14(20(26)27)18(25)13-7-11-8-15(21)17(9-16(11)23-19(13)24)22-12-5-3-2-4-6-12/h7-10,12,22H,2-6H2,1H3,(H,26,27)
Standard InChI Key: KGHFRVZGMZYRAN-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
7.5167 -1.9375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0875 -1.9500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0917 -2.7792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8000 -1.5292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8042 -3.1875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.5250 -2.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3792 -3.1917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3667 -1.5417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6625 -2.7792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2292 -1.5167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2292 -2.7875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6625 -1.9542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9417 -3.2000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2292 -1.9625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5167 -3.2000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9417 -1.5417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7917 -0.7042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.2167 -0.6917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5167 -1.5500 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.9417 -1.9250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.8167 -4.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5250 -4.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8125 -4.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2375 -4.4250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2417 -5.2500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8167 -5.2500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5292 -5.6625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 4 1 0
3 5 1 0
4 1 1 0
5 6 1 0
6 1 2 0
7 3 2 0
8 2 2 0
9 7 1 0
10 1 1 0
11 13 1 0
12 8 1 0
13 9 2 0
14 16 1 0
15 11 1 0
16 12 2 0
17 4 2 0
18 10 2 0
19 14 1 0
20 10 1 0
21 5 1 0
22 15 1 0
23 22 1 0
24 22 1 0
25 24 1 0
26 23 1 0
27 25 1 0
3 2 1 0
9 12 1 0
11 14 2 0
27 26 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 369.40Molecular Weight (Monoisotopic): 369.1489AlogP: 3.67#Rotatable Bonds: 3Polar Surface Area: 84.22Molecular Species: ACIDHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 5.73CX Basic pKa: 4.51CX LogP: 3.33CX LogD: 1.83Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.69Np Likeness Score: -0.92
References 1. Tabart M, Picaut G, Desconclois JF, Dutka-Malen S, Huet Y, Berthaud N.. (2001) Synthesis and biological evaluation of benzo[b]naphthyridones, a series of new topical antibacterial agents., 11 (7): [PMID:11294391 ] [10.1016/s0960-894x(01)00091-9 ]